Literature DB >> 20048054

FKBP51 promotes assembly of the Hsp90 chaperone complex and regulates androgen receptor signaling in prostate cancer cells.

Li Ni1, Chun-Song Yang, Daniel Gioeli, Henry Frierson, David O Toft, Bryce M Paschal.   

Abstract

Prostate cancer progression to the androgen-independent (AI) state involves acquisition of pathways that allow tumor growth under low-androgen conditions. We hypothesized that expression of molecular chaperones that modulate androgen binding to AR might be altered in prostate cancer and contribute to progression to the AI state. Here, we report that the Hsp90 cochaperone FKBP51 is upregulated in LAPC-4 AI tumors grown in castrated mice and describe a molecular mechanism by which FKBP51 regulates AR activity. Using recombinant proteins, we show that FKBP51 stimulates recruitment of the cochaperone p23 to the ATP-bound form of Hsp90, forming an FKBP51-Hsp90-p23 superchaperone complex. In cells, FKBP51 expression promotes superchaperone complex association with AR and increases the number of AR molecules that undergo androgen binding. FKBP51 stimulates androgen-dependent transcription and cell growth, and FKBP51 is part of a positive feedback loop that is regulated by AR and androgen. Finally, depleting FKBP51 levels by short hairpin RNA reduces the transcript levels of genes regulated by AR and androgen. Because the superchaperone complex plays a critical role in determining the ligand-binding competence and transcription function of AR, it provides an attractive target for inhibiting AR activity in prostate cancer cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20048054      PMCID: PMC2820886          DOI: 10.1128/MCB.01891-08

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  37 in total

1.  The Hsp90-binding peptidylprolyl isomerase FKBP52 potentiates glucocorticoid signaling in vivo.

Authors:  Daniel L Riggs; Patricia J Roberts; Samantha C Chirillo; Joyce Cheung-Flynn; Viravan Prapapanich; Thomas Ratajczak; Richard Gaber; Didier Picard; David F Smith
Journal:  EMBO J       Date:  2003-03-03       Impact factor: 11.598

2.  The FK506-binding immunophilin FKBP51 is transcriptionally regulated by progestin and attenuates progestin responsiveness.

Authors:  Tina R Hubler; Wesley B Denny; Donna L Valentine; Joyce Cheung-Flynn; David F Smith; Jonathan G Scammell
Journal:  Endocrinology       Date:  2003-06       Impact factor: 4.736

3.  The hsp90 cochaperone p23 is the limiting component of the multiprotein hsp90/hsp70-based chaperone system in vivo where it acts to stabilize the client protein: hsp90 complex.

Authors:  Yoshihiro Morishima; Kimon C Kanelakis; Patrick J M Murphy; Ezra R Lowe; Gary J Jenkins; Yoichi Osawa; Roger K Sunahara; William B Pratt
Journal:  J Biol Chem       Date:  2003-09-24       Impact factor: 5.157

4.  The influence of ATP and p23 on the conformation of hsp90.

Authors:  William P Sullivan; Barbara A L Owen; David O Toft
Journal:  J Biol Chem       Date:  2002-09-24       Impact factor: 5.157

Review 5.  Altered states: selectively drugging the Hsp90 cancer chaperone.

Authors:  Paul Workman
Journal:  Trends Mol Med       Date:  2004-02       Impact factor: 11.951

6.  Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays.

Authors:  Spyro Mousses; Lukas Bubendorf; Urs Wagner; Galen Hostetter; Juha Kononen; Robert Cornelison; Natalie Goldberger; Abdel G Elkahloun; Niels Willi; Pasi Koivisto; William Ferhle; Mark Raffeld; Guito Sauter; Olli-P Kallioniemi
Journal:  Cancer Res       Date:  2002-03-01       Impact factor: 12.701

7.  Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding.

Authors:  W B Denny; D L Valentine; P D Reynolds; D F Smith; J G Scammell
Journal:  Endocrinology       Date:  2000-11       Impact factor: 4.736

Review 8.  Immunophilin chaperones in steroid receptor signalling.

Authors:  Thomas Ratajczak; Bryan K Ward; Rodney F Minchin
Journal:  Curr Top Med Chem       Date:  2003       Impact factor: 3.295

9.  Molecular determinants of resistance to antiandrogen therapy.

Authors:  Charlie D Chen; Derek S Welsbie; Chris Tran; Sung Hee Baek; Randy Chen; Robert Vessella; Michael G Rosenfeld; Charles L Sawyers
Journal:  Nat Med       Date:  2003-12-21       Impact factor: 53.440

10.  Androgen receptor (AR) expression in AR-negative prostate cancer cells results in differential effects of DHT and IGF-I on proliferation and AR activity between localized and metastatic tumors.

Authors:  Stephen R Plymate; Marie K Tennant; Stephen H Culp; Lillie Woodke; Marco Marcelli; Ilsa Colman; Peter S Nelson; Julie M Carroll; Charles T Roberts; Joy L Ware
Journal:  Prostate       Date:  2004-11-01       Impact factor: 4.104

View more
  66 in total

1.  The stress response mediator ATF3 represses androgen signaling by binding the androgen receptor.

Authors:  Hongbo Wang; Ming Jiang; Hongmei Cui; Mengqian Chen; Ralph Buttyan; Simon W Hayward; Tsonwin Hai; Zhengxin Wang; Chunhong Yan
Journal:  Mol Cell Biol       Date:  2012-06-04       Impact factor: 4.272

Review 2.  Versatile TPR domains accommodate different modes of target protein recognition and function.

Authors:  Rudi Kenneth Allan; Thomas Ratajczak
Journal:  Cell Stress Chaperones       Date:  2010-12-09       Impact factor: 3.667

Review 3.  FKBP51 regulation of AKT/protein kinase B phosphorylation.

Authors:  Liewei Wang
Journal:  Curr Opin Pharmacol       Date:  2011-04-15       Impact factor: 5.547

Review 4.  FKBP51 and FKBP52 in signaling and disease.

Authors:  Cheryl L Storer; Chad A Dickey; Mario D Galigniana; Theo Rein; Marc B Cox
Journal:  Trends Endocrinol Metab       Date:  2011-08-31       Impact factor: 12.015

5.  Targeting the regulation of androgen receptor signaling by the heat shock protein 90 cochaperone FKBP52 in prostate cancer cells.

Authors:  Johanny Tonos De Leon; Aki Iwai; Clementine Feau; Yenni Garcia; Heather A Balsiger; Cheryl L Storer; Raquel M Suro; Kristine M Garza; Sunmin Lee; Yeong Sang Kim; Yu Chen; Yang-Min Ning; Daniel L Riggs; Robert J Fletterick; R Kiplin Guy; Jane B Trepel; Leonard M Neckers; Marc B Cox
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-05       Impact factor: 11.205

Review 6.  The role of FKBP5 in mood disorders: action of FKBP5 on steroid hormone receptors leads to questions about its evolutionary importance.

Authors:  John C O'Leary; Bo Zhang; John Koren; Laura Blair; Chad A Dickey
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-12       Impact factor: 4.388

7.  The cyclin D1-CDK4 oncogenic interactome enables identification of potential novel oncogenes and clinical prognosis.

Authors:  Siwanon Jirawatnotai; Samanta Sharma; Wojciech Michowski; Bhoom Suktitipat; Yan Geng; John Quackenbush; Joshua E Elias; Steven P Gygi; Yaoyu E Wang; Piotr Sicinski
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 8.  Constitutive activity of the androgen receptor.

Authors:  Siu Chiu Chan; Scott M Dehm
Journal:  Adv Pharmacol       Date:  2014

9.  Transcriptional activity of c-Jun is critical for the suppression of AR function.

Authors:  Chih-Chao Hsu; Chang-Deng Hu
Journal:  Mol Cell Endocrinol       Date:  2013-03-21       Impact factor: 4.102

10.  Differential impact of tetratricopeptide repeat proteins on the steroid hormone receptors.

Authors:  Jan-Philip Schülke; Gabriela Monika Wochnik; Isabelle Lang-Rollin; Nils Christian Gassen; Regina Theresia Knapp; Barbara Berning; Alexander Yassouridis; Theo Rein
Journal:  PLoS One       Date:  2010-07-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.